inverts or becomes flattened. The EKG reverts to normal within 4 months to 1 year following treatment.
A Model Program: Exercise Intervention for Cancer Rehabilitation C. M. Schneider, PhD, Carolyn A. Dennehy, PhD, Michelle Roozeboom, BS, and Susan D. Carter, MD Recent advances in cancer detection and treatment have resulted in an increase in the survival rate of individuals diagnosed with cancer. The increased survival rate brings new challenges for increasing the quality of life for cancer survivors. Debilitating side effects can result from the cancer itself and the cancer treatment. The negative effects lead to decreased functional (work) capacity, increased fatigue, and debilitating muscular weakness. There have been very positive benefits seen from the use of individualized prescriptive exercise intervention in alleviating these cancer treatment related symptoms. The role of exercise intervention as a complementary therapy is just emerging. Studies have shown that exercise decreases the amount of fatigue, improves functional capacity, increases immune function, and leads to improved quality of life. The effects of cancer and cancer treatments require that an exercise intervention program be well based in sound scientific principles. The exercise intervention needs to be carefully structured and controlled. All patients should be assessed and reassessed to evaluate progress. A cancer exercise specialist should closely monitor the exercise regime. Exercise should involve a whole-body approach that emphasizes all areas of fitness. Exercise therapy for cancer patients is a new and exciting area that will continue to grow as medical professionals realize the necessity for post-cancer treatment intervention to improve quality of life.
The American Cancer Society predicts that 1,268,000 new cancer cases will be reported in 2001.' The exciting news is that many will survive the disease. Presently, there are 8.9 million cancer survivors. Recent advances in cancer detection and treatment have resulted in an increase in the survival rate of individuals diagnosed with cancer. The increased survival rate brings new challenges for increasing the quality of life for survivors. Cancer treatments, although effective in eliminating cancer, lead to debilitating side effects in 72% to 96% of cancer patients who undergo treatment,.' i Cancer treatments such as chemotherapy, radiation, and surgery destroy or eliminate cancer cells, but in the process they destroy normal healthy tissue and alter normal tissue function. As a result of this added burden on the physiological systems, debilitating side effects occur.
Toxicities
Cancer patients experience a vast array of external symptoms and many potential internal alterations.
Toxicities can occur in the cardiovascular, immune, pulmonary, gastrointestinal, musculoskeletal, neuroendocrine, and hepatic systems. These physiological changes that occur within the body can manifest externally as decreased functional (energy) capacity, debilitating fatigue, and severe muscular weakness.
Cardiovascular Toxicity
Radiation has significant acute and chronic effects on the cardiovascular system. Most acute effects of radiation are found in the basal cells of the epidermis, the mucosal epithelia, and the hematopoietic cells of the bone marrow. However, the injury to cells in these areas leads to the release of substances (i.e., histamine) that cause inflammatory responses to the vasculature.
Inflammation leads to vascular dilatation, increased capillary permeability, and interstitial edema. Longterm effects on the vascular system occur with progressively reduced capillarization in the irradiated tissue, resulting in a decrease in blood perfusion/ Centrally, the pericardium, the myocardium, and the coronary arteries can be affected. With mediastinal radiotherapy, pericarditis (inflammation of the membranous sac enclosing the heart) is the most common side effect, lasting approximately 2 to 5 months. Radiation-induced pericarditis is fatal in about 6% of patients. Another cardiovascular abnormality appears in the electrocardiogram (EKG), where the T wave problems developing 6 to 23 years following radiation.
Reduced ventricular function has been found 5 to 15 years after radiation. Five years or more after mediastinal radiation, investigators found narrowing of the coronary arteries resulting in myocardial infarctions.
Vascular tissue alterations occur during treatment and are important because the tissue response to these alterations often produces chronic toxicity. Acute changes in the vascular tissue include edema, inflammation, and vascular spasms.
Chemotherapy agents (i.e., doxorubicin) can also directly damage the heart. There appears to be a gradual increase in heart damage with increased doses. The cardiomyopathy that occurs with chemotherapy appears in about 4 weeks following chemotherapy and has a higher incidence (50%) of fatality compared to radiation. There are abnormal occurrences seen on EKG. For example, QRS complexes have lower amplitudes, nonspecific ST and T wave changes, sinus tachycardia, prolongation of the QT interval, premature atrial and ventricular beats, and supraventricular arrhythmias. Chemotherapy has a profound affect on the bone marrow stem cell, causing myelosuppression throughout the vascular system Hematopoietic Toxicity Hematopoietic tissues (tissues that produce blood cells, i.e., bone marrow) are vulnerable to cancer therapy. Damage to the hematopoietic tissue results in leukopenia (low levels of white blood cells) and granulocytopenia (deficiency of neutrophils, which are the first line of defense against infection, basophils, and eosinophils). Thrombocytopenia (decreased numbers of circulating mature platelets causing bleeding) and anemia (low levels of red blood cells resulting in low concentrations of hemoglobin and decreased hematocrit levels) can also be caused by hematopoietic tissue damage. 78 R Pulmonary Toxicity Pulmonary toxicity may be acute or chronic, developing within days, months, or years following radiotherapy and chemotherapy. Long-term treatment may cause intra-alveolar pulmonary fibrosis (formation of scar tissue) and abnormal development of pulmonary tissue, especially the endothelial and epithelial cells. Patients may experience coughing, dyspnea, and a lowgrade fever as a result of pulmonary toxicity. Additionally, patients will have a diminished diffusion capacity and decreased pulmonary compliance within 8 months to 10 years after therapy. Pulmonary toxicity presents symptoms of fatigue, low exercise tolerance, restlessness, and tachypnea.' Gastrointestinal System Toxicity Radiotherapy causes acute changes in the intestinal mucosa, probably due to the damage to the cell reproductive cycle. The chronic intestinal changes include thickening of some of the bowel segments, stenosis (narrowing), ulceration, intestinal fibrosis, vascular edema and wall thickening, muscle hypertrophy, distortion of the arteries, and increased intestinal motility leading to diarrhea. Additionally, there are metabolic insufficiencies. There is a reduction of disaccharidases and aminopeptidases, the digestive enzymes involved in the catabolism of carbohydrates and proteins. The absorption capacity of the intestine is reduced, which can lead to protein deficiency, fat absorption abnormalities, and carbohydrate, vitamin, and electrolyte absorption impairments. Abdominal radiation can produce vomiting, nausea, and loss of appetite. The loss of the digestive and absorptive capacity of the nutrients in conjunction with loss of appetite can lead to malnutrition. This reduction in the capacity to produce energy leads to extreme fatigue, muscular wasting, and extreme muscular weakness.&dquo; R Chemotherapy-induced nausea and vomiting can lead to increased energy requirements, nutritional abnormalities, dehydration, and electrolyte imbalances. Depending on the type of chemotherapeutic agent, the patient can experience extensive morphological damage to the intestinal mucosa, leading to diarrhea, abdominal pain, and intestinal disease. In patients receiving certain antineoplastic drugs, constipation, distension, and abdominal pain are often reported.'
Musculoskeletal Alterations
As mentioned earlier, radiotherapy and chemotherapy alter bone marrow, which affects the vascularization of the bone and muscle as well as other tissues. It has been reported that muscle integrity is disturbed with radiation. Radiotherapy may alter the sarcolemma, sarcoplasmic reticulum (SR), and mitochondrial membranes, which lead to disturbances in the generation of muscle force. The loss of muscle force (muscle weakness) may be a result of the abnormalities in the recycling of Ca2+ by the SR and abnormalities in the Ca2+-ATPase system. Abnormalities in these mechanisms can lead to failure in the excitation-contraction coupling process, thus limiting muscle contraction. There is also some evidence that damage and disorganization occurs to the muscle myofibrils and myofilaments within the muscle. Patients may develop muscle wasting and cachexia. Cachexia is characterized by weight loss, anorexia, and weakness due to tissue necrosis resulting in decrements in muscle mass and body fat mass.&dquo;' Connective tissue alterations can occur during treatment. These alterations often produce chronic toxicity. Acute changes in the connective tissue, muscular tissue, and serous membrane include edema, hemorrhage, and inflammation.
Hepatic Toxicity Acute hepatic (liver) radiation toxicity usually presents within 2 to 6 weeks after completion of radiation, although manifestation of the toxicity may not occur for 6 months or longer. Symptoms of hepatic toxicity include rapid weight gain, increase in abdominal girth, fatigue, and anorexia. Liver enzymes are elevated in the blood serum.
Some chemotherapy agents such as 5-fluorouracil are hepatotoxic. However, to establish a direct effect on the liver is difficult. There appears to be liver injury causing hepatocyte necrosis, steatosis (fatty degeneration), and cholestasis (arrest of bile excretions). Chronic alterations to the liver include cytotoxic lesions, hepatic fibrosis (development of scar tissue), cirrhosis (disease of the liver), and chronic cholestasis (loss of bile excretion). Liver disease is usually temporary and can be controlled with careful therapeutic planning.&dquo; 9 Neuroendocrine Toxicity Radiotherapy of high doses can affect thyroid tissue, leading to cell necrosis and atrophy. Radiation-induced DNA damage and a continuous stimulation by thyroid stimulating hormone cause the major thyroid malfunction. Radiotherapy can also affect the hypothalamus and pituitary, causing abnormalities in growth and abnormalities in the release of growth hormone.
Chemotherapy-induced neurotoxicity includes a wide range of central nervous bilitation program that has shown significant benefits to cancer patients has been established. Clinical investigations on prescriptive exercise intervention for cancer treatment related symptoms have been completed. '1' Improvement in functional capacity, muscular strength, muscular endurance, and pulmonary function with a concomitant decrease in the perception of fatigue and feelings of depression has been consistently shown. Cancer exercise specialist workshops have been designed and implemented for individuals in all areas of the health profession and within our college curriculum. The institute sees the need to enhance the quality of life of cancer patients as a very real and critical concern.
Cancer rehabilitation programs should be comprehensive and address the multidimensional needs of the cancer patient during treatment and recovery. Staff for such a program should use health professionals, exercise physiologists, exercise and dietary specialists, and health management personnel. These individuals provide a mix of medical and scientific communities and lead to an integrative team approach to the treatment of cancer-related symptoms.
Essential Components of

Cancer Rehabilitation
The goal of cancer rehabilitation should be to provide appropriate assessment, prescription, and program guidelines for cancer patients during and following cancer treatment. Thus far, it has been determined that the essential components of cancer rehabilitation should include a physician referral and preassessment, physical examination, screening, a thorough fitness assessment, an individualized exercise prescription that outlines specific goals for a 6-month intervention program, and reassessment to determine the effectiveness of the intervention.
Physician referral is essential to the cancer rehabilitation program. In many instances, cancer patients appear to be &dquo;apparently healthy&dquo; because many of the symptoms associated with cancer and cancer treatments are not obvious, and yet can be serious and life threatening.
In addition to a physician referral, it is essential to get meticulous information from the patient prior to the assessment. From the information collected, appropriate assessment techniques and protocols can be determined. Screening should be comprehensive.
Because the effects of cancer treatments are multidimensional, screening should include physiological screening (i.e., physical examination, medical history, etc.) and psychological screening (i.e., quality of life indices, etc.).
Effective assessment should include relevant measurable parameters that are valid and reliable. The assessment procedures should be rigidly controlled so that exact procedures can be repeated during the reassessment. The patient's rights and privacy should be protected during all procedures. Accurate interpretation of the assessment data is critical for the development of an appropriate individualized exercise prescription. A thorough assessment prior to the exercise intervention will help determine appropriate or contraindicated activities during the exercise intervention. The assessment provides baseline information that can be used to monitor physiological alterations that occur during or following cancer treatment.
The individualized exercise prescription is developed after careful analysis of the patient's type of cancer, cancer treatment, and length of time out of treatment. In addition, data from the assessment are factored into the prescription goals, recommendations, and precautions.
Trained cancer exercise specialists should be responsible for carefully designing the 6-month exercise intervention program from the exercise prescription. The 3-day-per-week program should accomplish the intended goals and improve the patient's functional capacity. The activities completed each session are recorded in the patient's logbook. Prior to each session, a brief health and fatigue status report is obtained from the patient. Modifications of the exercise intervention are made based on changes in treatment regimens, alterations in drug therapy, or as a result of any new developments in health status. The rate of progression during the exercise intervention is based on the modifications made in the patient's exercise prescription due to the above considerations. The exercise intervention will be significantly different between patients during treatment and posttreatment. The specialist outlines an exercise program that uses a whole-body approach toward exercise. All areas of physical fitness are emphasized during each exercise session. The activities that are prescribed should be both aerobic (endurance) and anaerobic (strength) in nature.
Following the 6-month exercise intervention program, the cancer patient again completes all the assessment procedures that were used before exercise intervention. The differences between the preassessment values and the reassessment values help determine the effectiveness of the exercise intervention. The reassessment also helps determine modifications in the exercise prescription for the next 6-month exercise intervention.
Ancillary services should be provided to meet the special needs of the patients. Possible services may include psychological counseling, physical therapy, massage therapy, occupational therapy, and information on other applicable services throughout the community.
Exercise Program Guidelines
An exercise intervention is designed from the exercise prescription, which is developed from the screening, physical examination, and assessment data. The exercise intervention guidelines for patients during treatment and following treatment encompass a sequential rehabilitation model integrating whole bodywork and progressing to specific affected tissues and systems. The sequential model for patients during treatment encompasses a slow progression with continuous monitoring and adjustments if the health status of the patient changes. The exercise intervention for patients following treatment also follows a rehabilitation model rather than a model strictly for the development of fitness. Usually, the exercise intervention following treatment will not have the severe patient fluctuations that are seen with patients during treatment.
The first 4 months of the exercise program for patients during treatment focus on the whole body, since total body fatigue seems to be prevalent among cancer patients. The goal of the exercise intervention is to keep the patient active while undergoing cancer treatment. The intervention will fluctuate depending on the patient's tolerance for the treatment regimen.
During weeks 4 through 6, the intervention contains mostly whole bodywork for the purpose of minimizing treatment fatigue. However, the intervention can also include rehabilitation of a specific area that was affected by cancer, such as working on range of motion in a surgical breast cancer patient who is undergoing a regime of chemotherapy.
The exercise intervention for patients following treatment is also a sequential rehabilitation model.
Patients in this model can progress somewhat faster;
however, this is dependent on the progress reports and status of the patient. The first 3 months of the exercise program for patients following treatment again focus on the whole body. The exercise intervention includes whole bodywork; however, rehabilitation becomes more specific to the muscle groups and systems affected by the type of cancer and cancer treatment within the next month. Finally, the exercise workouts contain a whole-body component and become very specific to the physiological components (i.e., range of motion work for a surgical breast cancer patient) that need to be rehabilitated for the patient to gain even more advances toward improved quality of life (4 to 6 months).
Special Considerations
for Cancer Rehabilitation Patients will present for cancer rehabilitation with numerous complications due to their cancer and/or cancer treatments. Surgical patients will presentwith recent incisions and sutures, with the possibility of developing infection. Therefore, it is important to monitor factors within your facility that will reduce the possibil-ity of infection. These factors include cleanliness of floors, equipment, locker rooms, pools, spas, and the air filtration system. Another complication that needs to be addressed with surgical patients is the pain they experience with movement. The exercise program needs to be designed to minimize the patient's pain and maximize the patient's comfort. A possible strategy is to exercise the nonsurgical side until the patient can tolerate exercise movement on the affected side.
Additionally, the surgical patient experiences changes in body image (mastectomy). These changes may be difficult for the patient to perceive positively. Actual or perceived body changes usually cause severe anxiety. The reactions of the staff will influence the patient's ability to adapt to changes in body image. With a surgical patient, there is always the possibility of edema (swelling). This is a symptom that must be monitored.
Patients who have received radiation therapy will present with similar and yet very different complications compared to surgery patients. Radiation causes acute and chronic skin reactions. Skin reactions are described in degrees: (1) first-degree skin reaction is characterized by loss of hair in the radiated area; (2) second-degree skin reaction shows skin redness in the radiated area, with inhibition or loss of sweat glands; (3) third-degree skin reaction shows deep redness in the skin, blisters, destruction of the sweat glands, and permanent hair loss; and (4) fourth-degree skin reaction shows deep blisters and ulcerations and significant pain.' If leukopenia (low levels of circulating mature white blood cells) occurs, the patient is susceptible to infection. Care must be given during the exercise intervention to reduce infection, eliminate skin irritation, and prevent an excessive rise in body temperature. Additionally, the patient may experience other physiological symptoms (e.g., nausea, diarrhea, anemia, thrombocytopenia) that can require a modification in the exercise prescription. Dehydration is also a side effect of radiation; therefore, the exercising patient must have plenty of fluids available. Edema in the affected area needs to be monitored and precautions taken to eliminate any causes of swelling.
Chemotherapy patients have complications that also must be addressed by professionals during exercise intervention. Leukopenia, which increases the patient's chance of infection, must be monitored. Many chemotherapy patients experience thrombocytopenia (decreased numbers of circulating mature platelets); therefore, precautions need to be taken during activities that may produce bleeding, such as blood collection. The chemotherapy patient is susceptible to bruising; therefore, be careful with patients using free weights, dumbbells, and so on. The patient can also experience negative symptoms during treatment (e.g., nausea, diarrhea, vomiting) that will alter the exercise prescription. Ensure adequate hydration during exercise to prevent further complications. Additionally, it is essential to understand the effects of the various chemotherapy drugs on the parameters that are used to assess exercise intensity such as heart rate and blood pressure.
Patients with bone marrow transplantation have altered immune status, leaving them vulnerable to infection. There are also bleeding tendencies and anemia, which must be taken into consideration when exercising patients following bone marrow transplantation. Blood values in a bone marrow transplant patient, especially total leukocyte count, platelet count, and hemoglobin concentration, must be followed closely by the cancer rehabilitation facility physician and by the cancer exercise specialist.
Summary
Acute and chronic exercise can enhance the cardiovascular system both centrally and peripherally. The physiological changes that occur reduce the stress on the heart and blood vessels, thus enhancing an individual's functional aerobic capacity or ability of the heart and lungs to more efficiently deliver oxygen to the working tissues. The evidence obtained at the Rocky Mountain Cancer Rehabilitation Institute'S22 has shown significant improvements in functional capacity, resting heart rate, time on treadmill, forced vital capacity, and range of motion with concomitant reductions in perception of fatigue and depression following 6-month exercise interventions in cancer patients compared to nonexercise cancer patient controls. Additionally, muscular alterations such as disruption of the sarcolemma, disruption of the sarcoplasmic reticulum, and damage to the myofibrils and myofilaments can lead to muscle weakness and loss of force production. Evidence by the aforementioned investigators showed that muscular strength and endurance significantly improved in cancer patients. In fact, the muscular weakness that was observed in the cancer patients appeared to be more highly correlated with the debilitating fatigue experienced by patients than with cardiovascular endurance.
The careful attention directed to the special considerations for cancer rehabilitation, the implementation of each of the essential components, and the use of the exercise prescription guidelines thus far developed by the Rocky Mountain Cancer Rehabilitation Institute have shown positive improvements in the physiological and psychological health of cancer patients, with no concomitant adverse effects. Thus, the following important points for the development of the exercise prescription and exercise intervention for cancer patients should be noted:~ Be keenly aware of the special considerations that should be accounted for during cancer rehabilitation. Provide comprehensive physiological and psychological assessments to develop appropriate exercise prescriptions and exercise interventions. The individualized exercise prescription and intervention program is based on the type of cancer, stage of cancer, severity of treatment, and time out of treatment.
The exercise intervention is continuously monitored and changed if the health status of the patient changes. The variability in the exercise prescriptions and exercise interventions emphasize the importance of having trained cancer exercise specialists. The exercise prescription and exercise intervention program should be based on appropriate modes, frequency, intensity, duration, and progression of exercises. Manipulation of these parameters determines the exercise dose. Exercise dose has been reported as having an influence on the immune system. It appears as if a moderate exercise dose has a positive effect on the immune system, whereas being sedentary and exercising intensely has a negative effect on the immune system.&dquo; Be sure to maintain a logbook of the exercise workout to maintain continuity for the patient. Editor's Note The Rocky Mountain Cancer Rehabilitation Institute is one of several programs offering exercise interventions for cancer patients. C. M. Schneider and colleagues have outlined the medical background and organization of this comprehensive, institutionally based exercise program for cancer patients, which is attuned to the many potential physical complications of cancer and its treatments. These complications highlight the need for physical assessment and prescriptive exercise programs for cancer patients. Benefits of such interventions are clear; however, some are noted in other publications of this group. A reviewer suggested, additionally, that the exercise program may have positive impacts on depression, which is noted frequently among cancer patients, and that this could contribute to favorable outcomes of exercise treatment. The beneficial effect of exercise on major depressive disorder' and on depression in breast cancer patients' has been noted in recent clinical studies.
We note that this article mentions the monitoring of bone marrow transplant patients by physicians and other staff of rehabilitation-oriented institutions. Bone marrow transplant patients are likely to be monitored quite intensively by their oncology specialists, who should be specifically informed about any exercise programs their patients undertake. Where the staff of rehabilitation institutions might be of considerable assistance is in the monitoring of patients who have completed standard-dose chemotherapeutic regimens, who tend to be monitored less closely than bone marrow transplant patients.
